<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LUP</journal-id>
<journal-id journal-id-type="hwp">splup</journal-id>
<journal-id journal-id-type="nlm-ta">Lupus</journal-id>
<journal-title>Lupus</journal-title>
<issn pub-type="ppub">0961-2033</issn>
<issn pub-type="epub">1477-0962</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0961203312443338</article-id>
<article-id pub-id-type="publisher-id">10.1177_0961203312443338</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus</article-title>
</title-group>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>21</volume>
<issue>6</issue>
<fpage>688</fpage>
<lpage>688</lpage>
<permissions>
<copyright-statement>© The Author(s), 2012. Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Z Racz, E Nagy, L Rosivall, J Szebeni and P Hamar, published in <related-article ext-link-type="doi" id="ra1-0961203312443338" page="599" related-article-type="corrected-article" vol="19" xlink:href="10.1177/0961203309355299">Lupus (2010) 19, 599–612, DOI: 10.1177/0961203309355299</related-article></p>
<p>The author’s would like to make the following correction to <xref ref-type="table" rid="table1-0961203312443338">table 1</xref>. The published data were not divided by the number of cases.
<table-wrap id="table1-0961203312443338" position="float">
<graphic alternate-form-of="table1-0961203312443338" xlink:href="10.1177_0961203312443338-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th>IVIG (n = 8)</th>
<th>Saline (n = 10)</th>
<th>P-value</th></tr></thead>
<tbody align="left">
<tr>
<td>Macroscopic</td>
<td/>
<td/>
<td/></tr>
<tr>
<td> Skin</td>
<td>0.75 ± 0.34</td>
<td>1.3 ± 0.4</td>
<td>&lt;0.03</td></tr>
<tr>
<td> Ear</td>
<td>0.25 ± 0.12</td>
<td>0.8 ± 0.2</td>
<td>&lt;0.05</td></tr>
<tr>
<td>Microscopic</td>
<td/>
<td/>
<td/></tr>
<tr>
<td> Dermal changes</td>
<td>0.58 ± 0.47</td>
<td>1.21 ± 0.58</td>
<td>0.001</td></tr>
<tr>
<td> Basement membrane thickening</td>
<td>0.41 ± 0.2</td>
<td>0.95 ± 0.54</td>
<td>0.001</td></tr>
<tr>
<td> Hyper-and/or parakeratosis</td>
<td>0.39 ± 0.1</td>
<td>0.66 ± 0.28</td>
<td>0.02</td></tr>
<tr>
<td> Stratum spinosum thickening</td>
<td>0.23 ± 0.11</td>
<td>0.61 ± 0.28</td>
<td>0.212</td></tr>
<tr>
<td> Ulceration</td>
<td>0.11 ± 0.33</td>
<td>0.4 ± 0.51</td>
<td>0.089</td></tr>
<tr>
<td> Inflammatory inflammation</td>
<td>0.35 ± 0.21</td>
<td>0.75 ± 0.42</td>
<td>0.123</td></tr>
<tr>
<td> Summarized average microscopic scores</td>
<td>0.34 ± 0.29</td>
<td>0.76 ± 0.56</td>
<td>0.05</td></tr>
</tbody>
</table>
</table-wrap></p>
<p>Table 1 should be as follows:</p>
<p>The title of the table (Skin disease: macroscopic and microscopic scores of intravenous immunoglobulin (IVIG) and saline-treated MRL/lpr mice) is correct. The changes do not influence description of these results or their discussion.</p>
<p>The authors would like to apologize for any inconvenience caused.</p>
</body>
</article>